Loading...

RadNet, Inc.

RDNTNASDAQ
Healthcare
Medical - Diagnostics & Research
$57.83
$0.42(0.73%)

RadNet, Inc. (RDNT) Company Profile & Overview

Explore RadNet, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

RadNet, Inc. (RDNT) Company Profile & Overview

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOHoward G. Berger

Contact Information

310 478 7808
1508, 1510 and 1516 Cotner Avenue, Los Angeles, CA, 90025-3303

Company Facts

11,000 Employees
IPO DateJan 3, 1997
CountryUS
Actively Trading

Frequently Asked Questions

;